Intrinsiqs

Is PACS Group, Inc. overvalued?

PACS Group, Inc. (PACS) looks overvalued — trading about 24% above its fair value.

Overvalued
Current price $48.32 Fair value $36.74
Price
$48.32
Fair value
$36.74
Current P/E
41.1
Normal P/E
31.2
Market cap
$7.67B
Dividend yield
0.0%
Return on equity
25.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PACS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.